STRIDES PHARMA SCIENCE
Intrinsic Value | Fundamental Analysis

BOM : 532531     NSE : STAR    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : High [>50%]
May 20,2022
Price(EOD): β‚Ή 307.60
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: β‚Ή 2,762.25 Cr
Value of β‚Ή 1 Lac invested in STRIDES PHARMA SCIENCE
on May 22,2017 (price: β‚Ή 937.90)

β‚Ή 1 L

β‚Ή 0.33 L

1W : 3.8% 1M : -8.9% 1Y : -63.5%
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Industry Peers & Returns1W1M1Y
STRIDES PHARMA SCIENCE 3.8% -8.9% -63.5%
SUN PHARMACEUTICAL INDUSTRIES 3.4% -0.8% 28%
DIVIS LABORATORIES 2.1% -3.3% 4.4%
DR REDDYS LABORATORIES 9.2% -1.1% -24.4%
CIPLA 4.9% -3.3% 6.1%
GLAND PHARMA -1.3% -6.3% 1%
PIRAMAL ENTERPRISES 2.3% -13.7% 12%
CADILA HEALTHCARE 3.5% -0.9% -44%
TORRENT PHARMACEUTICALS 3.1% -6.9% -4.9%

FUNDAMENTAL ANALYSIS OF STRIDES PHARMA SCIENCE

 
Fundamentals Score
[ Q(TTM): Dec2021, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF STRIDES PHARMA SCIENCE

 
Valuation Score
[As on : May 20,2022 ]

Ratio Consolidated
P/E
P/B
P/S
10.28
P/E Calculated based on EPS of 29.93
[ Mar2021 - Consolidated Results ]

1
P/B Calculated based on Book Value of 309.09
[ Mar2021 - Consolidated Results ]

0.89
P/S Calculated based on Revenues of 3112.73 Cr
[ TTM - Consolidated Results ]

Financial Ratios →

Insights πŸ’‘ STAR is one of the potential top 20% undervalued companies ! Discover More →

FAIR VALUE OF STRIDES PHARMA SCIENCE

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-29%
-60%
-51%

Insights πŸ’‘ You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF STRIDES PHARMA SCIENCE


Insights πŸ’‘ There are 7% companies with bullish price momentum currently! Discover More →

STRIDES PHARMA SCIENCE vs SENSEX


Insights πŸ’‘ You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF STRIDES PHARMA SCIENCE

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
0.27
0.27
0.25
0.26
0.76
0.78
1.22
0.92
[Last Annual Data : Mar2021]
Financial Ratios →

PLEDGED PROMOTER SHARES OF STRIDES PHARMA SCIENCE

Pledged Promoter Shares
56.67 %
As on : Mar2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF STRIDES PHARMA SCIENCE

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
10.11%
111.28%
29.41%
29.2%
-4.52%
-99.04%
-246.69%
-264.94%
QtrlyTrend
0
Latest Qtr: Dec2021
Quarterly Result Analysis →


STRIDES PHARMA SCIENCE related INDICES

BSE Indices1W1M1Y
S&P BSE 250 SMALLCAP 4.5% -9.8% 12.8%
S&P BSE SMALL CAP 4.1% -8.7% 16.8%
S&P BSE MIDSMALLCAP 3.7% -8.4% 12.6%
S&P BSE 400 MIDSMALLCAP 3.6% -7.9% 11.9%
S&P BSE ALLCAP 3.2% -5.8% 10.3%
S&P BSE 500 3.2% -5.6% 9.7%
S&P BSE HEALTHCARE 2.8% -6.4% -4.8%
NSE Indices1W1M1Y
NIFTY SMALLCAP250 4.5% -10% 13.6%
NIFTY PHARMA 3.5% -3.4% -5.7%
NIFTY MID SMALL400 3.4% -8% 12.5%
NIFTY500 MULTICAP 50:25:25 3.4% -6.8% 11%
NIFTY 500 3.1% -5.7% 9.7%

You may also like the below Video Courses


FAQ about STRIDES PHARMA SCIENCE


Is STRIDES PHARMA SCIENCE good for long term investment?

As on May 20,2022, the Fundamentals of STRIDES PHARMA SCIENCE look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of STRIDES PHARMA SCIENCE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is STRIDES PHARMA SCIENCE UnderValued or OverValued?

As on May 20,2022, STRIDES PHARMA SCIENCE is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of STRIDES PHARMA SCIENCE ?

As on May 20,2022, the Intrinsic Value of STRIDES PHARMA SCIENCE is Rs. 629.36 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 432.93
Fair Value [Median EV / Sales Model] : Rs. 759.68
Fair Value [Median Price / Sales Model] : Rs. 629.36
Median Fair Value of STRIDES PHARMA SCIENCE : Rs. 629.36

Is STRIDES PHARMA SCIENCE trading at a Premium or Discount?

As on May 20,2022, STRIDES PHARMA SCIENCE is trading at a Discount of -51% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z